MONTREAL–(BUSINESS WIRE)–Immervision, the Montreal-based developer and licensor of patented, wide-angle optics and imaging technology announces two new licensing agreements for the production and distribution of patented panomorph wide-angle lenses w…
Category: Business
Global Eyeglasses Market 2020-2024 | 7% CAGR Projection Over the Next Five Years | Technavio
LONDON–(BUSINESS WIRE)– #ApparelsandAccessories–The eyeglasses market size is expected to post a CAGR of over 7% during the period 2020-2024 according to Technavio
Aldeyra Therapeutics Appoints Nancy Miller-Rich to Board of Directors
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today an…
OptiKira, Leader in Unfolded Protein Response Therapeutics to Present at the BIOTECH SHOWCASE, January 13, 2020
RADNOR, Pa.–(BUSINESS WIRE)– #JPM20–OptiKira, Leader in Unfolded Protein Response Therapeutics to Present at the Biotech Showcase, January 13, 2020
Haymarket Medical Education Receives Interprofessional Joint Accreditation for the Healthcare Team
PARAMUS, N.J.–(BUSINESS WIRE)– #CME–Caroline O. Pardo, Ph.D., General Manager for Haymarket Medical Education (HME), is pleased to announce that HME, based in Paramus, NJ, has been accredited as a provider of interprofessional continuing education (…
Gemini Therapeutics Enrolls First Patient in Phase 1 Study of GEM103 for Dry Age-related Macular Degeneration
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics has enrolled the first patient in its Phase 1 study of GEM103 for dry age-related macular degeneration.
Midwest Vision Partners Announces Partnership With Michigan Eye Institute
CHICAGO & FLINT, Mich.–(BUSINESS WIRE)–Midwest Vision Partners (“MVP”) is pleased to announce its partnership with Michigan Eye Institute (“MEI”). This represents MVP’s first partnership in Michigan. MVP is a people-focused eye care management servic…
Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical company developing a new class of tumor targeted therapies for initial application in primary tumors such as ocular and bladder cancers, today announced the appoint…
OTITOPIC™ Announces Results of Dose-Finding PK/PD Study for ASPRIHALE® Dry Powder Inhalation of Aspirin for Acute Myocardial Infarction (MI)
LOS ANGELES–(BUSINESS WIRE)–OTITOPIC™ Announces Results of Dose-Finding PK/PD Study for ASPRIHALE® Dry Powder Inhalation of Aspirin for Acute Myocardial Infarction (MI)
North America Dry Eye Syndrome Market by Disease Type, Drug Type, Product, Distribution Channel and Region – Forecast to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Dry Eye Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The North America dry eye syndrome market reached…
Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% Marketing Authorisation Application in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Acucela to Participate in Biotech Showcase™ 2020
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo: 4596), announced today its participation in Biotech Showcase™ 2020, being held in…
Acucela Announces Publication of Pre-clinical Data for Emixustat Hydrochloride
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of pre-clinical data related to the company…
5,736位世界最貧困人士於2019年在Tej Kohli角膜研究所獲贈視力恢復手術
倫敦–(BUSINESS WIRE)–(美國商業資訊)–在總部位於海德拉巴的Tej Kohli角膜研究所4週年慶之際,Tej Kohli基金會已更新其承諾,將自2020年起資助1400萬美元。在2019年期間,5,736位失明或重度視力受損者在Tej Kohli角膜研究所獲得治癒,該所是總部位於倫敦的Tej Kohli基金會與總部位於海德拉巴的世界衛生組織合作中心LV Prasad眼科研究所之間的合作。 Tej Kohli角膜研究所成立於2015年12月,為任何有需求的人士提供免費治療,以解決…
5,736位世界最贫困人士2019年在Tej Kohli角膜研究所获赠视力恢复手术
伦敦–(BUSINESS WIRE)–(美国商业资讯)–在总部位于海得拉巴的Tej Kohli角膜研究所4周年庆之际,Tej Kohli基金会已更新其承诺,将自2020年起资助1400万美元。在2019年期间,5,736位失明或重度视力受损个体在Tej Kohli角膜研究所获得治愈,该所是总部位于伦敦的Tej Kohli基金会与总部位于海得拉巴的世界卫生组织协作中心LV Prasad眼科研究所之间的合作。 Tej Kohli角膜研究所成立于2015年12月,旨在通过向任何有需求的人士提供免费治…
Midwest Vision Partners Announces Partnership With Cleveland Eye Clinic
CHICAGO & CLEVELAND–(BUSINESS WIRE)–Alpine Investors’ Midwest Vision Partners (“MVP”) partners with Cleveland Eye Clinic (“CEC”).
ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institute
LONDON–(BUSINESS WIRE)–On the fourth anniversary of the Tej Kohli Cornea Institute in Hyderabad, the Tej Kohli Foundation has renewed its commitment of $14m of funding from 2020. During 2019 5,736 individuals were cured of blindness or severe visual …
Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today an…
STAAR CFO to Retire in 2020
LAKE FOREST, CA–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that following a successful 24-year career with th…